BDNF and depressive symptom measurement: We observed that fluoxetine treatment improved the cefaclor-induced reduction of serotonin and BDNF levels as well as the expression of pro-inflammatory cytokines, resulting in decrease anxiety- and depression-like behaviors in mice.